We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy (ADI-PEG 20)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01287585
Recruitment Status : Completed
First Posted : February 1, 2011
Last Update Posted : August 26, 2016
Information provided by (Responsible Party):
Polaris Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2015
  Study Completion Date : July 2015
  Certification or Request for Extension to Delay Results Submission: August 10, 2016